Ryan M Byrne

7PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

|Jun 03, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Feb 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

|Jun 13, 2023
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

Toshiyasu Suzuki, Anna Kilbey, Nuria Casa-Rodríguez

|Jan 30, 2023
MmCMS: mouse models' consensus molecular subtypes of colorectal cancer.

Raheleh Amirkhah, Kathryn Gilroy, Sudhir B Malla

|Jul 06, 2022
Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.

Natalie C Fisher, Ryan M Byrne, Holly Leslie

Pageof 2

Frequent Collaborators

7 joint publications

Philip D Dunne

5 joint publications

Sudhir B Malla

5 joint publications

Simon Leedham

5 joint publications

Owen J Sansom